MEI Pharma Inc. Stock
Pros and Cons of MEI Pharma Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MEI Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| MEI Pharma Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 0.300% | -17.606% | -21.563% | -62.646% | -25.224% | -63.158% | -94.320% |
| Evolus Inc | -1.700% | 29.834% | 28.415% | -61.157% | -13.761% | -43.373% | -53.070% |
| Sangamo Therapeutics Inc. | 4.330% | -11.687% | -2.689% | -65.867% | -6.890% | -86.006% | -96.452% |
Comments
MEI Pharma (NASDAQ:MEIP) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Show more
Ratings data for MEIP provided by MarketBeat
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for MEIP provided by MarketBeat
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for MEIP provided by MarketBeat